Regulatory

Latest News

FDA Approves Merz Aesthetics’ Xeomin for Simultaneous Treatment of Upper Facial Lines
FDA Approves Merz Aesthetics’ Xeomin for Simultaneous Treatment of Upper Facial Lines

July 23rd 2024

The new approval expands Xeomin’s indications to include horizontal forehead lines and lateral canthal lines.

Johnson & Johnson Submits Supplemental New Drug Application to FDA for Spravato as Monotherapy for Adults with Treatment-Resistant Depression
Johnson & Johnson Submits Supplemental New Drug Application to FDA for Spravato as Monotherapy for Adults with Treatment-Resistant Depression

July 22nd 2024

FDA Grants Orphan Drug Designation to Mabwell’s Treatment of Small Cell Lung Cancer
FDA Grants Orphan Drug Designation to Mabwell’s Treatment of Small Cell Lung Cancer

July 18th 2024

FDA Clears Positrigo’s NeuroLF Brain PET System for the Diagnosis of Multiple Brain Disorders
FDA Clears Positrigo’s NeuroLF Brain PET System for the Diagnosis of Multiple Brain Disorders

July 17th 2024

FDA Grants Fast Track Designation to Abdera Therapeutics’ Treatment for Extensive-Stage Small Cell Lung Cancer
FDA Grants Fast Track Designation to Abdera Therapeutics’ Treatment for Extensive-Stage Small Cell Lung Cancer

July 17th 2024

More News